866-997-4948(US-Canada Toll Free)

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2018 in Pharmaceuticals

Published By :

GlobalData

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 77 Pages

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2018 in Pharmaceuticals

Summary

GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for August 2018 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in August 2018. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Pharmaceuticals & Healthcare, Global, Deal Summary 10
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, August 2018 10
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, August 2018 12
2.2.1 Affimed to Enter into Co-Development Agreement with Genentech 12
2.2.2 Consortium of Investors to Acquire Remaining Shares in China Biologic Products for USD3.9 Billion 12
2.2.3 AstraZeneca Prices Public Offering of Notes USD3 Billion 13
2.2.4 Beijing New Oriental Star Petrochemical Engineering to Acquire Jiangsu Aosaikang Pharmaceutical for USD1.2 Billion 13
2.2.5 Emergent BioSolutions to Acquire Adapt Pharma for up to USD735 Million 13
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, August 2018 15
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, August 2018 16
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 17
3.1 Pharmaceuticals & Healthcare, Global, M&A, August 2018 17
3.1.1 Top M&A Deals in August 2018 18
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, March 2018 - August 2018 18
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, August 2018 20
3.2.1 Top Equity Offering Deals in August 2018 21
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, March 2018 - August 2018 22
3.2.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, August 2018 23
3.2.4 Top PE/VC Deals in August 2018 24
3.2.5 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, August 2018 25
3.2.6 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, August 2018 26
3.2.7 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, March 2018-August 2018 27
3.2.8 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2018-August 2018 28
3.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, August 2018 29
3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, March 2018 - August 2018 30
3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), August 2018 31
3.5.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, August 2018 32
3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), March 2018 - August 2018 33
3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, March 2018 - August 2018 35
3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), March 2018 - August 2018 36
3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2018 - August 2018 37
4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2018 39
4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2018 39
4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), August 2018 40
4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), March 2018 - August 2018 41
4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), March 2018 - August 2018 42
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), March 2018 - August 2018 43
4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), March 2018 - August 2018 45
4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, August 2018 46
4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, August 2018 47
4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, August 2018 47
5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 48
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, August 2018 48
5.1.1 Oncology - Deals of the Month 49
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, August 2018 51
5.2.1 Central Nervous System - Deals of the Month 52
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, August 2018 53
5.3.1 Infectious Diseases - Deals of the Month 54
5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, August 2018 55
5.4.1 Cardiovascular - Deal of the Month 56
5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, August 2018 57
5.5.1 Immunology - Deal of the Month 58
5.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, August 2018 59
5.6.1 Gastrointestinal - Deal of the Month 60
5.7 Pharmaceuticals & Healthcare, Global, Dermatology, Deals, August 2018 61
5.7.1 Dermatology - Deal of the Month 62
6 Deal Summary by Geography 63
6.1 Pharmaceuticals & Healthcare, North America Deals, August 2018 63
6.1.1 North America - Deals of the Month 64
6.2 Pharmaceuticals & Healthcare, Europe, Deals, August 2018 66
6.2.1 Europe - Deals of the Month 67
6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, August 2018 69
6.3.1 Asia-Pacific - Deals of the Month 70
6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, August 2018 71
6.4.1 Rest of the World - Deals of the Month 72
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 73
7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, March 2018 - August 2018 73
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, March 2018 - August 2018 74
8 Further Information 75
8.1 Methodology 75
8.2 About GlobalData 76
8.3 Contact Us 76
8.4 Disclosure information 76
8.5 Disclaimer 77

1.1 List of Tables
Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 11
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, August 2018 12
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), August 2018 16
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 17
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, August 2018 18
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2018 - August 2018 19
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 21
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, August 2018 21
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 22
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 24
Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, August 2018 24
Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, March 2018 - August 2018 25
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), August 2018 27
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 28
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2018 - August 2018 28
Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 29
Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 30
Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2018 - August 2018 31
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), August 2018 32
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2018 - August 2018 34
Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2018 - August 2018 36
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), March 2018 - August 2018 38
Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 39
Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), March 2018 - August 2018 40
Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 41
Table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), August 2018 42
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2018 - August 2018 44
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), August 2018 46
Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, August 2018 46
Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, August 2018 47
Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, August 2018 47
Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 49
Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 52
Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 54
Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 56
Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 58
Table 37: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 60
Table 38: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 62
Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 64
Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 67
Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 70
Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 71
Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 73
Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 74

1.2 List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 10
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), August 2018 15
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), August 2018 16
Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 17
Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2018 - August 2018 18
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 20
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 22
Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 23
Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2018 - August 2018 25
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), August 2018 26
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), August 2018 26
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 27
Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 29
Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 30
Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2018 - August 2018 31
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2018 - August 2018 33
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2018 - August 2018 35
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2018 - August 2018 36
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2018 - August 2018 37
Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 39
Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2018 - August 2018 40
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 41
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2018 - August 2018 42
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, March 2018 - August 2018 43
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), March 2018 - August 2018 44
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), August 2018 45
Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 48
Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 51
Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 53
Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 55
Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 57
Figure 32: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 59
Figure 33: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 61
Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 63
Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 66
Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 69
Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 71
Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 73
Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), March 2018 - August 2018 74

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *